A Comparison of Ketofol (Ketamine and Propofol Admixture) Versus Propofol as Induction Agents on Hemodynamic Parameters
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01065350 |
Recruitment Status :
Completed
First Posted : February 9, 2010
Results First Posted : May 3, 2013
Last Update Posted : May 3, 2013
|
Sponsor:
Mayo Clinic
Collaborator:
Dartmouth-Hitchcock Medical Center
Information provided by (Responsible Party):
Nathan J. Smischney, Mayo Clinic
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor); Primary Purpose: Prevention |
Condition |
Blood Pressure |
Interventions |
Drug: Propofol Drug: Ketamine |
Enrollment | 85 |
Participant Flow
Recruitment Details | Patients requiring surgical procedures with general anesthesia were recruited and enrolled at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire from December 2010 to March 2011. |
Pre-assignment Details |
Arm/Group Title | Propofol | Ketofol |
---|---|---|
![]() |
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL. | As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose. |
Period Title: Overall Study | ||
Started | 43 | 42 |
Completed | 43 | 41 |
Not Completed | 0 | 1 |
Reason Not Completed | ||
Received incorrect drug allocation | 0 | 1 |
Baseline Characteristics
Arm/Group Title | Propofol | Ketofol | Total | |
---|---|---|---|---|
![]() |
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL. | As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose. One subject in the ketofol group was excluded from analysis due to incorrect study drug assignment and outside the protocol-specified dose. | Total of all reporting groups | |
Overall Number of Baseline Participants | 43 | 41 | 84 | |
![]() |
[Not Specified]
|
|||
Age Continuous
Mean (Standard Deviation) Unit of measure: Years |
||||
Number Analyzed | 43 participants | 41 participants | 84 participants | |
43 (11) | 42 (12) | 42.68 (11.51) | ||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 43 participants | 41 participants | 84 participants | |
Female |
28 65.1%
|
27 65.9%
|
55 65.5%
|
|
Male |
15 34.9%
|
14 34.1%
|
29 34.5%
|
|
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
||||
United States | Number Analyzed | 43 participants | 41 participants | 84 participants |
43 | 41 | 84 | ||
Body Weight
Mean (Standard Deviation) Unit of measure: Kilograms |
||||
Number Analyzed | 43 participants | 41 participants | 84 participants | |
69.2 (11.7) | 68.9 (11.2) | 68.97 (11.41) | ||
Body Height
Mean (Standard Deviation) Unit of measure: Centimeters |
||||
Number Analyzed | 43 participants | 41 participants | 84 participants | |
169.9 (9.1) | 168.9 (9.2) | 169.40 (9.03) | ||
Systolic Blood Pressure
[1] Mean (Standard Deviation) Unit of measure: Millimeters of mercury (mm Hg) |
||||
Number Analyzed | 43 participants | 41 participants | 84 participants | |
125 (17) | 122 (15) | 124.19 (16.41) | ||
[1]
Measure Description: Mean pre-operative systolic blood pressure
|
||||
Diastolic Blood Pressure
[1] Mean (Standard Deviation) Unit of measure: Millimeters of mercury (mm Hg) |
||||
Number Analyzed | 43 participants | 41 participants | 84 participants | |
76 (12) | 76 (10) | 76 (11) | ||
[1]
Measure Description: Mean pre-operative diastolic blood pressure
|
||||
Heart Rate
[1] Mean (Standard Deviation) Unit of measure: Beats per minute |
||||
Number Analyzed | 43 participants | 41 participants | 84 participants | |
72 (16) | 73 (14) | 73 (15) | ||
[1]
Measure Description: Mean pre-operative heart rate
|
||||
American Society of Anesthesiology (ASA) Physical Status
[1] Measure Type: Number Unit of measure: Participants |
Number Analyzed | 43 participants | 41 participants | 84 participants |
ASA Status 1 | 21 | 14 | 35 | |
ASA Status 2 | 22 | 27 | 49 | |
[1]
Measure Description:
ASA Physical Status 1 - A normal healthy patient ASA Physical Status 2 - A patient with mild systemic disease |
Outcome Measures
Adverse Events
Limitations and Caveats
The dose ratio implemented was not ideal. Enrollment was limited to ASA I and II patients only.
More Information
Results Point of Contact
Name/Title: | Nathan J. Smischney, MD |
Organization: | Mayo Clinic |
Phone: | 507-255-6032 |
EMail: | smischney.nathan@mayo.edu |
Responsible Party: | Nathan J. Smischney, Mayo Clinic |
ClinicalTrials.gov Identifier: | NCT01065350 |
Other Study ID Numbers: |
22063 |
First Submitted: | February 7, 2010 |
First Posted: | February 9, 2010 |
Results First Submitted: | February 15, 2013 |
Results First Posted: | May 3, 2013 |
Last Update Posted: | May 3, 2013 |